002437.SZ
Harbin Gloria Pharmaceuticals Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 3.94
−9.43%Sep 14, 2026, 12:23 UTC
Certain directors and senior executives of Yuheng Pharmaceutical plan to collectively reduce their holdings by no more than 11.5709 million shares, or 0.5189% of total share capital, via centralized bidding.
Source:Aug 26, 2026, 08:43 UTC
Yuhuan Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 159 million yuan, up 18.27% year-on-year, with revenue of 1.007 billion yuan, down 8.41%.
Source: